| A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS U Keilholz, A Letsch, A Busse, AM Asemissen, S Bauer, IW Blau, ... Blood, The Journal of the American Society of Hematology 113 (26), 6541-6548, 2009 | 383 | 2009 |
| CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia C Scheibenbogen, A Letsch, E Thiel, A Schmittel, V Mailaender, ... Blood, The Journal of the American Society of Hematology 100 (6), 2132-2137, 2002 | 317 | 2002 |
| Natural T cell immunity against cancer D Nagorsen, C Scheibenbogen, FM Marincola, A Letsch, U Keilholz Clinical Cancer Research 9 (12), 4296-4303, 2003 | 267 | 2003 |
| Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity V Mailänder, C Scheibenbogen, E Thiel, A Letsch, IW Blau, U Keilholz Leukemia 18 (1), 165-166, 2004 | 218 | 2004 |
| Natural T-cell Response against MHC Class I Epitopes of Epithelial Cell Adhesion Molecule, her-2/neu, and Carcinoembryonic Antigen in Patients with Colorectal … D Nagorsen, U Keilholz, L Rivoltini, A Schmittel, A Letsch, AM Asemissen, ... Cancer research 60 (17), 4850-4854, 2000 | 179 | 2000 |
| Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer P Ghadjar, SE Coupland, IK Na, M Noutsias, A Letsch, A Stroux, S Bauer, ... J Clin Oncol 24 (12), 1910-1916, 2006 | 162 | 2006 |
| Gender medicine and oncology: report and consensus of an ESMO workshop AD Wagner, S Oertelt-Prigione, A Adjei, T Buclin, V Cristina, C Csajka, ... Annals of Oncology 30 (12), 1914-1924, 2019 | 158 | 2019 |
| Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining A Letsch, C Scheibenbogen Methods 31 (2), 143-149, 2003 | 124 | 2003 |
| Functional CCR9 expression is associated with small intestinal metastasis A Letsch, U Keilholz, D Schadendorf, G Assfalg, AM Asemissen, E Thiel, ... Journal of Investigative Dermatology 122 (3), 685-690, 2004 | 116 | 2004 |
| Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction U Keilholz, P Goldin-Lang, NE Bechrakis, N Max, A Letsch, A Schmittel, ... Clinical cancer research 10 (5), 1605-1612, 2004 | 115 | 2004 |
| Effects of granulocyte‐macrophage colony‐stimulating factor and foreign helper protein as immunologic adjuvants on the T‐cell response to vaccination with tyrosinase peptides C Scheibenbogen, D Schadendorf, NE Bechrakis, D Nagorsen, ... International journal of cancer 104 (2), 188-194, 2003 | 92 | 2003 |
| Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells AM Asemissen, D Nagorsen, U Keilholz, A Letsch, A Schmittel, E Thiel, ... Journal of immunological methods 251 (1-2), 101-108, 2001 | 92 | 2001 |
| Identification of a highly immunogenic HLA-A* 01-binding T cell epitope of WT1 AM Asemissen, U Keilholz, S Tenzer, M Müller, S Walter, S Stevanovic, ... Clinical Cancer Research 12 (24), 7476-7482, 2006 | 82 | 2006 |
| Bone Marrow Contains Melanoma-reactive CD8+ Effector T Cells and, Compared with Peripheral Blood, Enriched Numbers of Melanoma-reactive CD8+ Memory … A Letsch, U Keilholz, G Assfalg, V Mailänder, E Thiel, C Scheibenbogen Cancer research 63 (17), 5582-5586, 2003 | 76 | 2003 |
| High frequencies of circulating melanoma‐reactive CD8+ T cells in patients with advanced melanoma A Letsch, U Keilholz, D Schadendorf, D Nagorsen, A Schmittel, E Thiel, ... International journal of cancer 87 (5), 659-664, 2000 | 73 | 2000 |
| Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from … M Mossner, JC Jann, D Nowak, U Platzbecker, A Giagounidis, K Goetze, ... Leukemia 30 (9), 1956-1959, 2016 | 72 | 2016 |
| Wilms tumor protein 1 (WT1)—not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma ET Taube, C Denkert, J Sehouli, CA Kunze, M Dietel, I Braicu, A Letsch, ... Gynecologic oncology 140 (3), 494-502, 2016 | 62 | 2016 |
| Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy R Arsenic, EI Braicu, A Letsch, M Dietel, J Sehouli, U Keilholz, ... BMC cancer 15, 1-11, 2015 | 60 | 2015 |
| Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2 R Godal, U Keilholz, L Uharek, A Letsch, AM Asemissen, A Busse, IK Na, ... Blood 107 (8), 3205-3211, 2006 | 58 | 2006 |
| Human peripheral blood and bone marrow Epstein–Barr virus‐specific T‐cell repertoire in latent infection reveals distinct memory T‐cell subsets M Guerreiro, IK Na, A Letsch, D Haase, S Bauer, C Meisel, A Roemhild, ... European journal of immunology 40 (6), 1566-1576, 2010 | 48 | 2010 |
